Cosmeceuticals for Recurrence Prevention After Prior Skin Cancer: An Overview

被引:0
|
作者
Franca, Katlein [1 ]
Cohen, Joel L. [3 ]
Grunebaum, Lisa [2 ]
机构
[1] Univ Miami, Miller Sch Med, Dept Dermatol & Cutaneous Surg, Miami, FL 33136 USA
[2] Univ Miami, Miller Sch Med, Dept Otolaryngol Facial Plast & Reconstruct Surg, Miami, FL 33136 USA
[3] AboutSkin Dermatol & DermSurg, Englewood, CO USA
关键词
ACTINIC KERATOSES; RISK;
D O I
暂无
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Introduction: Skin cancer is the most common form of cancer in the United States. According to the World Health Organization, the incidence of both nonmelanoma and melanoma skin cancers has increased over the past few decades. Objective: The objective of this article is to review studies about cosmeceuticals that can be used by people who previously had skin cancer and may work as agents that help in some way to prevent new skin cancer lesions. Conclusion: Cosmeceuticals are antiaging skin products that overlap cosmetics and pharmaceuticals and are commonly available over the counter. This article reviewed several substances used in cosmeceuticals formulations that could be useful for individuals who have had previous skin cancers and need to prevent possible new lesions. Further studies are needed to better evaluate these products and their skin cancer preventive properties.
引用
收藏
页码:516 / 518
页数:3
相关论文
共 50 条
  • [11] Recurrence outcomes for nonmelanoma skin cancer after adjuvant radiation
    Cannon, John
    Li, Shufeng
    Chang, Anne Lynn
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2018, 79 (03) : AB241 - AB241
  • [12] Anesthesia and cancer recurrence: an overview
    Brogi, Etrusca
    Forfori, Francesco
    JOURNAL OF ANESTHESIA ANALGESIA AND CRITICAL CARE, 2022, 2 (01):
  • [13] OVERVIEW OF CANCER PREVENTION
    Sinclair, Craig
    Hill, David
    CANCER FORUM, 2012, 36 (01) : 3 - 4
  • [14] An overview of cancer prevention
    Sugimura, T
    EUROPEAN JOURNAL OF CANCER PREVENTION, 1996, 5 : 1 - 8
  • [15] Treatment of PSA only recurrence of prostate cancer after prior local therapy
    Moul, JW
    CURRENT PHARMACEUTICAL DESIGN, 2006, 12 (07) : 785 - 798
  • [16] Predictors of recurrence after radiotherapy for non-melanoma skin cancer
    Khan, L.
    Breen, D.
    Zhang, L.
    Balogh, J.
    Czarnota, G.
    Lee, J.
    Tsao, M. N.
    Barnes, E. A.
    CURRENT ONCOLOGY, 2014, 21 (02) : E326 - E329
  • [17] Prognosis for Isolated Skin Recurrence after Breast Cancer Treated by Mastectomy
    Jaffre, Frederique
    Lavoue, Vincent
    Mesbah, Habiba
    Rouquette, Sophie
    Audrain, Odile
    Laurent, Jean Francois
    Leveque, Jean
    ANTICANCER RESEARCH, 2009, 29 (05) : 1697 - 1701
  • [18] Commentary on Recurrence Rates of Nonmelanoma Skin Cancer After Malignant Destruction
    Soon, Seaver L.
    DERMATOLOGIC SURGERY, 2020, 46 (07) : 977 - 978
  • [19] Recurrence After Treatment of Nonmelanoma Skin Cancer A Prospective Cohort Study
    Chren, Mary-Margaret
    Torres, Jeanette S.
    Stuart, Sarah E.
    Bertenthal, Daniel
    Labrador, Remedios J.
    Boscardin, John
    ARCHIVES OF DERMATOLOGY, 2011, 147 (05) : 540 - 546
  • [20] Dose Response of Retinol and Isotretinoin in the Prevention of Non-Melanoma Skin Cancer Recurrence
    Clouser, Mary C.
    Roe, Denise J.
    Foote, Janet A.
    Harris, Robin B.
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2009, 18 : S111 - S111